2,5—取代—1,3,4—恶二唑化合物库的固相合成

本文使用组合化学方法以聚苯乙烯亚磺酸钠树脂为载体合成了２，５－取代－１，３，４－恶二唑化合物库。树脂１首先与溴代乙酸乙酯反应聚合物支载的乙酸酯。肼解后所得的肼树脂进一步与取代的苄氯反应得双酰肼树脂。树脂４与三氯氧磷回流得聚合物支载的２，５－取代－１，３，４－恶二唑。     

2-[1-(1,2,4-三唑)甲基]-3-乙酰基-2,5-二取代芳基-1,3,4-噁二唑啉类化合物的合成

在冰醋酸存在下, 4-取代苯乙酮和溴素容易进行溴代反应, 得到α-溴-4-取代苯乙酮; 将其和1,2,4-三唑在丙酮中反应, 得到α-(1,2,4-三唑-1-基)-4-取代苯乙酮2; 在冰醋酸催化下, 2和4-取代苯甲酰肼1进行缩合, 得到相应酰腙衍生物3; 化合物3在乙酸酐的作用下环化生成一系列2-[1-(1,2,4-三唑)甲基]-3-乙酰基-2,5-二取代芳基-1,3,4-噁二唑啉4. 化合物4的结构经IR, 1H NMR, MS, 元素分析和单晶衍射确证.     

3-聚苯乙烯磺酰基丙醇的制备及其在固相有机合成中的应用

本文采用聚苯乙烯亚磺酸钠树脂1与3-氯丙醇在碘化四正丁胺和碘化钾的存在下反应制备了3-聚苯乙烯磺酰基丙醇树脂2.以该树脂为载体固载了Boc保护的L-丙氨酸,再经封羟基、脱保护、中和,与异氰酸苯酯反应制得聚合物支载的脲6.脲树脂6在酸性或强碱条件下解脱得到取代的海因化合物,在弱碱条件下解脱得到取代的脲化合物.     

含1,2,4-三唑和1,3,4-噁二唑硫醚类化合物的合成及结构表征

在KOH溶液中,芳甲酰肼(2)与CS2生成钾盐3;然后3在水合肼作用下经过环化、取代、肼解得3-巯基-4-氨基-5-苯基-4H-1,2,4-三唑-乙酸酰肼(6),6再与CS2回流成环生成化合物5-(4-氨基-5-苯基-4H-1,2,4-三唑-3-硫烷基)-1,3,4-噁二唑-2-硫醇(7),最后7与取代苄基氯反应得目标化合物A1～A6,与芳基甲醛反应得终产物B1～B15.目标化合物的结构均经1H NMR,13C NMR,IR,MS或HRMS确证结构.     

(Z)-3,3-二甲基-1-(1H-1,2,4-三唑-1-基)-2-丁酮肟(5-芳基-1,3,4-噁二唑-2-基)甲基醚的合成和抑菌活性

以3,3-二甲基-1-（1H-1,2,4-三唑基）-2-丁酮肟为原料,经醚化、肼解及腙化3步反应得到（E）-N'-（取代苯亚甲基）-2-[（Z）-3,3-二甲基-1-（1H-1,2,4-三唑-1-基）丁基-2-亚甲氨氧基]乙酰肼（3a~3u）,化合物3与二乙酸碘苯（IBD）反应,合成了21个（Z）-3,3-二甲基-1-（1H-1,2,4-三唑-1-基）-2-丁酮肟-（5-芳基-1,3,4-噁二唑-2-基）甲基醚（4a~4u）,化合物4的化学结构经核磁共振谱、高分辨质谱和元素分析确证.采用单晶X射线衍射仪测定了化合物4c的晶体结构.抑菌活性测试结果表明,在500 mg/L浓度下,化合物4k,4f,4j和4n对纹枯病菌的防效率分别为70.9%,60.2%,60.0%和60.6%;在25 mg/L浓度下,化合物4b,4c,4d和4e对菌核病菌的抑制率为71.8%~76.9%.     

5-(4-氟苯基)-1,3,4-噁二唑-2-巯基乙酰腙类化合物的合成、表征及生物活性

以4-氟苯甲酸为原料,经过酯化、肼解、关环生成5-(4-氟苯基)-1,3,4-噁二唑-2-硫酮,再与溴乙酸乙酯、水合肼反应得到中间体2-[(4-氟苯基)-1,3,4-噁二唑-2-硫基]-乙酰肼,最后中间体酰肼与取代苯甲醛在冰乙酸中回流得到一系列含有1,3,4-噁二唑环的乙酰腙类化合物。目标化合物结构经元素分析、IR、1H NMR、ESI-MS得到确证,并通过K-B纸片法初步测定了它们的生物活性。结果表明,部分化合物具有一定的抑菌活性。     

含1,3,4-噁二唑和1,3,4-噻二唑的硫醚类化合物的合成

在KOH作用下,芳甲酰肼1a～1e与CS2环化生成5-芳基-2-巯基-1,3,4-噁二唑(2a～2e);将2a～2e与氯乙酸乙酯反应,生成2-(5-芳基-1,3,4-噁二唑)硫基乙酸乙酯(3a～3e);3a～3e肼解得2-(5-苯基-1,3,4-噁二唑-2-硫基)乙酰肼(4a～4e);4a～4e与芳酰基异硫氰酸酯5a～5d反应得到双酰基氨基硫脲衍生物A1～A19;A1～A19在H2SO4催化下环合得到目标化合物B1～B19;目标化合物的结构经IR,1H NMR,MS,HRMS确证.     

1/2,5-二取代吲唑-3-甲酰胺衍生物的合成及其抗肿瘤活性

以吲唑-3-羧酸为原料,依次经溴代和酯化反应制得中间体5-溴吲唑-3-羧酸甲酯(2);2经N-烷基化并原位水解生成1/2-取代-5-溴吲唑-3-羧酸(3);3与吡啶酮甲胺类化合物经缩合反应制得酰胺(4);4与芳基频哪醇硼酸酯发生Suzuki偶联反应合成了14个新型二取代吲唑-3-甲酰吡啶酮甲胺衍生物(5a~5n),收率26%~32%,其结构经~1H NMR,~(13)C NMR和HR-MS(ESI-TOF)表征。通过NOE差谱确证了取代基在吲唑氮原子上的取代位置。采用MTT法研究了5a~5n对人B淋巴瘤细胞(Ramos)、人黑色素瘤细胞(CHL-1,WM-266-4)和乳腺癌细胞(BT-474)的体外抗肿瘤活性。结果表明:5a,5b,5m对Ramos细胞、5a,5b,5l对WM-266-4细胞、5a,5b,5d,5e,5h,5j,5m,5n对CHL-1细胞和5a,5b,5d,5h,5m对BT-474细胞具有较好的抑制活性(IC5010.0μmol.L-1)。     

2-聚苯乙烯磺酰基乙醇树脂的合成及其在海因和脲固相成中的应用

合成了一种新型的聚合物载体—2-聚苯乙烯磺酰基乙醇，并研究其在固相有机合成中应用，聚苯乙烯亚磺酸钠树脂（1）在相转移催化剂BU4NI和助催化KI的作用下，与氯乙进行砜化反应，得到含羟基功能基的2-聚苯乙烯磺酰基乙醇树脂2。树脂2用Boc保护的氨基酯化，封闭树脂上未反应的羟基，用酸脱保护并用三乙胺中和，再与异（硫）氰酸苯酯反应生成聚合生物支载的脲树脂6树脂6用酸解脱得到海因和硫代海因化合物，用碱处理树脂6是得到取代的脲和硫脲，优化了合成反应的全过程，探讨了树脂在酸性和碱性条件下的解脱方法，结果表明，2-聚苯乙烯磺酰基乙醇树脂易与羧基形成含酯键的连接桥，连接桥在强酸性和碱性条件下均可解脱得到产物。     

3-取代胺甲基-5-连三唑基-1,3,4-噁二唑-2-硫酮的合成

2-苯基-1,2,3-三唑-4-甲酰肼(1)在CS_2/KOH作用下环化得到5-(2-本基-1,2,3-连三唑-4-基)-1,3,4-噁二唑-2-硫酮(2),2经Mannich反应合成得到标题化合物3-取代胺甲基-5-(2-本基-1,2,3-连三唑-4-基)-1,3,4-噁二唑-2-硫酮(3)。     

N-2-氯苄基苯甲酰胺的固相合成及其晶体结构分析

N-2-氯苄基苯甲酰胺采用固相法制备.聚苯乙烯磺酰氯(1)在吡啶存在下与2-氯苄胺反应得到N-2-氯苄基磺酰胺树脂(2),进一步在吡啶催化下用苯甲酰氯进行酰化得到N-2-氯苄基-N-苯甲酰基磺酰胺树脂(3).用TiCl₄/Zn/THF试剂处理,从树脂3上解脱得到产物N-2-氯苄基苯甲酰胺(4),产率92%.N-2-氯苄基苯甲酰胺的晶体属于单斜晶系,P2₁空间群,晶胞参数:a=0.7149(3)_nm,b=0.8772(4)_nm,c=0.9704(4)_nm;β=95.172(7)°;晶体结构中存在两种分子间氢键相互作用.     

Synthesis of oxadiazoles, thiadiazoles and triazoles derived from benzo[b]thiophene

In this work 3-chloro-2-chlorocarbonylbenzo[b]thiophene (1) was prepared from cinnamic acid and then converted into the acid hydrazide 2. The azomethines 3a-e were prepared from the corresponding aryl aldehydes and the acid hydrazide 2. Treatment of compound 2 with formic acid gave the N-formyl acid hydrazide 4, which upon refluxing with phosphorous pentoxide or phosphorous pentasulphide in xylene yielded the corresponding 2- (3-chloro-1-benzothien-2-yl)-1,3,4-oxadiazole (5) and 2-(3-chloro-1-benzo-thien-2-yl)-1,3,4- thiadiazole (6). Reaction of 1-thiosemicarbazide 7 with NaOH leads to ring closure giving 5- (3-chloro-1-benzothien-2- yl)-4H-triazole-3-thiol (8) which is converted into a number of derivatives 9-12 Reaction of 2 with phenyl isothiocyanate and NaOH afforded 5-(3-chloro- 1-benzothien-2-yl)-4-(phenyl)-4H-1,2,4-triazole-3-thiol (14).     

SOLID PHASE SYNTHESIS OF ISOXAZOLINES

1. INTRODUCTION A solid phase organic synthesis (SPOS) has increasingly attracted chemist抯 attention over the past decades [1~3]. It was found that the compounds with biological activity are mostly derived from heterocycle structures. It is therefore no…     

SOLID PHASE SYNTHESIS OF ISOXAZOLINES

The solid-phase synthesis of isoxazolines on 2-polystyrylsulfonamidoethanol resin isreported. 2-Polystyrylsuifonamidoethanol resin 1 was reacted with acryloyl chloride to afford2-polystyrylsulfonylamidoethyl acrylate resin 2, which was further reacted with brominatedaldoximes by [3+2] cycioaddition to give isoxazoline resin 4. Resin 4 was treated with aqueous 6mol/L HCI solution to obtain isoxazolines in good yield and purity.     

Structure based library approach to photosynthesis inhibitors:Combinatorial synthesis of hydrouracil library

Ｌｉｆｅｏｎｅａｒｔｈｄｅｐｅｎｄｓｏｎｔｈｅｃｈｅｍｉｃａｌｓｙｎｔｈｅｓｉｓ,ｓｔｏｒａｇｅａｎｄｄｅｌｉｖｅｒｙｏｆｅｎｅｒｇｙ＿ｒｉｃｈｏｒｇａｎｉｃｃｏｍｐｏｕｎｄｓｉｎｐｌａｎｔｓｏｒｇｒｅｅｎａｌｇａｅ.ＯｎｅｏｆｔｈｅｍａｉｎｓｔｅｐｓｉｎｔｈｉｓｐｒｏｃｅｓｓｉｓａｃｃｏｍｐｌｉｓｈｅｄｂｙｐｈｏｔｏｓｙｓｔｅｍＩＩ(ＰＳＩＩ),ｗｈｉｃｈｃａｔａｌｙｓｅｓｔｈｅｔｒａｎｓｆｅｒｏｆｅｌｅｃｔｒｏｎｓｆｒｏｍｗａｔｅｒｔｏｐｌａｓｔｏｑｕｉｎｏｎｅ.Ｔｈｅｓｐｅｃｉｆｉｃｉｎｈｉｂｉ…     

2-芳基-5-(6-哒嗪酮-3-基)-1,3,4-噁二唑的合成

1,4,5,6-四氢-6-哒嗪酮-3-甲酰肼(1)和1,6-二氢-6-哒嗪酮-3-甲酰肼(2)与芳香醛反应得到相应的芳香醛腙3a～3g和5a～5g, 再将3a～3g, 5a～5g在溴的作用下, 合环得到一系列1,3,4-噁二唑的衍生物4a～4g和6a～6g. 化合物的结构经1H NMR, IR, MS和元素分析得以证实.     

Preparation of Resin-Bound Bismethylene Cyclic Malonic Acid Ester and Facile Solid-Phase Synthesis of 2-Alkylthio-4(1H)-quinolone and 2-Alkyl-4(1H)-quinolone

Abstract

The resin-bound bismethylthiomethylene cyclic malonic acid ester 3 was built up efficiently. Resin 3 can react with arylamines and subsequent thermal cyclizations give 2-alkylthio-4-(1H)-quinolones. Furthermore, conjugate addition of Grignard reagents to the resin 3 forms the resin 6 which was reacted with aryl amines and subsequent thermal-cyclization-cleavages afford the 2-alkyl-4-(1H)-quinolones.     

6-硝基苯并咪唑杂环衍生物的合成

以６－硝基苯并咪唑－１－乙酰肼和５－（６－硝基苯并咪唑－１－亚甲基）－３－巯基－４－氨基－１,２,４－三唑为原料,在不同条件下合成了一系列新的均三唑〔３,４－ｂ〕－１,３,４－噻二唑,１,２,４－三唑和１,３,４－恶二唑衍生物。化合物的结构均经元素分析、＾１Ｈ ＮＭＲ、ＩＲ和ＭＳ确证,并对其波谱性质进行了讨论。     

Synthesis of 1,2,4-Triazol-3-ylmethyl-, 1,3,4-Oxa-, and -Thiadiazol-2-ylmethyl-1H-[1,2,3]-triazolo[4,5-d]pyrimidinediones

1-Carbethoxymethyl-4,6-dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione was synthesized and treated with hydrazine hydrate to give the corresponding hydrazide. The latter hydrazide was treated either with phenylisothiocyanate or with carbon disulfide/alc. KOH to afford the corresponding thiosemicarbazide and oxadiazole derivatives. Alkylation of 2-mercapto-1,3,4-oxadiazole with dimethyl sulfate or ethyl chloroacetate gave the corresponding 2-methylthio-, and 2-ethylthioglycolate derivatives. Formation of 1,3,4-thiadiazole, 5-mercapto-1,2,4-triazole, and 1,3,4-oxadiazole were carried out by treating of the latter thiosemicarbazide with conc. H₂SO₄, NaOH/HCl, and HgO. Treating of 5-mercapto-1,2,4-triazole with ethyl chloroacetate afforded the thioglycolate ester. Hydrolysis of the latter with hydrazine hydrate afforded the hydrazide derivatives. Condensation of these hydrazides with monosaccharide aldoses gave the corresponding sugar hydrazones. The novel compounds were tested for antiviral activity against hepatitis B virus and showed moderate activities.     

Synthesis of 1,2,4-Triazol-3-ylmethyl-, 1,3,4-Oxa-, and -Thiadiazol-2-ylmethyl-1<Emphasis Type="Italic">H</Emphasis>-[1,2,3]-triazolo[4,5-<Emphasis Type="Italic">d</Emphasis>]pyrimidinediones

Summary. 1-Carbethoxymethyl-4,6-dimethyl-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione was synthesized and treated with hydrazine hydrate to give the corresponding hydrazide. The latter hydrazide was treated either with phenylisothiocyanate or with carbon disulfide/alc. KOH to afford the corresponding thiosemicarbazide and oxadiazole derivatives. Alkylation of 2-mercapto-1,3,4-oxadiazole with dimethyl sulfate or ethyl chloroacetate gave the corresponding 2-methylthio-, and 2-ethylthioglycolate derivatives. Formation of 1,3,4-thiadiazole, 5-mercapto-1,2,4-triazole, and 1,3,4-oxadiazole were carried out by treating of the latter thiosemicarbazide with conc. H₂SO₄, NaOH/HCl, and HgO. Treating of 5-mercapto-1,2,4-triazole with ethyl chloroacetate afforded the thioglycolate ester. Hydrolysis of the latter with hydrazine hydrate afforded the hydrazide derivatives. Condensation of these hydrazides with monosaccharide aldoses gave the corresponding sugar hydrazones. The novel compounds were tested for antiviral activity against hepatitis B virus and showed moderate activities.